Comprehensive real-time dashboard tracking global malaria vaccine development across all clinical trial phases. Monitor breakthrough developments, enrollment progress, and emerging candidates fighting one of the world's deadliest diseases.
Small-scale safety testing in 20-100 healthy volunteers to assess safety and immune response
Expanded testing in 100-500 participants in endemic areas to evaluate efficacy and optimal dosing
Large-scale trials with 1,000-10,000+ participants to confirm efficacy and monitor adverse events
Vaccines that have received WHO prequalification and regulatory approval for use